Patent applications and USPTO patent grants for BIOATLA, LLC.The latest application filed is for "humanized anti-cd73 antibodies".
Patent | Date |
---|---|
Proteins targeting orthologs Grant 11,293,929 - Short April 5, 2 | 2022-04-05 |
Conditionally active polypeptides and methods of generating them Grant 11,279,924 - Short , et al. March 22, 2 | 2022-03-22 |
Conditionally active biological proteins Grant 11,254,932 - Short , et al. February 22, 2 | 2022-02-22 |
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof Grant 11,254,742 - Short , et al. February 22, 2 | 2022-02-22 |
Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof Grant 11,149,088 - Short , et al. October 19, 2 | 2021-10-19 |
Conditionally active chimeric antigen receptors for modified t-cells Grant 11,111,288 - Short , et al. September 7, 2 | 2021-09-07 |
Humanized Anti-cd73 Antibodies App 20210253727 - Griffin; Emily Piccione ;   et al. | 2021-08-19 |
Protein Therapeutics For Treatment Of Senescent Cells App 20210230221 - Short; Jay M. | 2021-07-29 |
Modified antibody regions and uses thereof Grant 10,954,288 - Frey , et al. March 23, 2 | 2021-03-23 |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Grant 10,920,216 - Short February 16, 2 | 2021-02-16 |
Conditionally Active Polypeptides App 20200407439 - SHORT; Jay M. ;   et al. | 2020-12-31 |
Methods of protein evolution Grant 10,829,513 - Short November 10, 2 | 2020-11-10 |
Humanized anti-CD73 antibodies Grant 10,822,426 - Griffin , et al. November 3, 2 | 2020-11-03 |
Comprehensive Monoclonal Antibody Generation App 20200256875 - A1 | 2020-08-13 |
Discovering And Producing Conditionally Active Biologic Proteins In The Same Eukaryotic Cell Production Hosts App 20200216834 - Short; Jay M. | 2020-07-09 |
Multi-specific monoclonal antibodies Grant 10,696,750 - Frey , et al. June 30, 2 | 2020-06-30 |
Diagnostics using conditionally active antibodies Grant 10,697,972 - Short | 2020-06-30 |
Conditionally Active Biological Proteins App 20200199578 - Short; Jay M. ;   et al. | 2020-06-25 |
Conditionally Active Polypeptides And Methods Of Generating Them App 20200190503 - Short; Jay M. ;   et al. | 2020-06-18 |
Comprehensive monoclonal antibody generation Grant 10,670,608 - Short | 2020-06-02 |
Express Humanization Of Antibodies App 20200157247 - Short; Jay M. | 2020-05-21 |
Express humanization of antibodies Grant 10,562,981 - Short Feb | 2020-02-18 |
Conditionally active biological proteins Grant 10,563,194 - Short , et al. Feb | 2020-02-18 |
Anti-ror2 Antibodies, Antibody Fragments, Their Immunoconjucates And Uses Thereof App 20200002414 - Short; Jay M. ;   et al. | 2020-01-02 |
Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts Grant 10,513,699 - Short Dec | 2019-12-24 |
Conditionally Active Biological Proteins App 20190284551 - Short; Jay M. ;   et al. | 2019-09-19 |
Conditionally active biological proteins Grant 10,329,556 - Short , et al. | 2019-06-25 |
Anti-axl Antibodies, Antibody Fragments And Their Immunoconjugates And Uses Thereof App 20190177417 - Short; Jay M. ;   et al. | 2019-06-13 |
Multi-specific Monoclonal Antibodies App 20190153120 - Frey; Gerhard ;   et al. | 2019-05-23 |
Humanized Anti-cd73 Antibodies App 20190077873 - Griffin; Emily Piccione ;   et al. | 2019-03-14 |
Conditionally Active Biological Proteins App 20190024078 - Short; Jay M. ;   et al. | 2019-01-24 |
Conditionally Active Chimeric Antigen Receptors For Modified T-cells App 20190010220 - Short; Jay M. ;   et al. | 2019-01-10 |
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells App 20190010219 - Short; Jay M. | 2019-01-10 |
Simultaneous, Integrated Selection And Evolution Of Antibody/protein Performance And Expression In Production Hosts App 20180371452 - Short; Jay Milton | 2018-12-27 |
Novel Methods Of Protein Evolution App 20180362576 - Short; Jay M. | 2018-12-20 |
Conditionally Active Chimeric Antigen Receptors For Modified T-cells App 20180340021 - Short; Jay M. | 2018-11-29 |
Methods of protein evolution Grant 10,106,576 - Short October 23, 2 | 2018-10-23 |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Grant 10,106,788 - Short October 23, 2 | 2018-10-23 |
Proteins Targeting Orthologs App 20180259536 - Short; Jay M. | 2018-09-13 |
Multi-specific Monoclonal Antibodies App 20180237543 - Frey; Gerhard ;   et al. | 2018-08-23 |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Grant 10,047,357 - Short August 14, 2 | 2018-08-14 |
Modified Antibody Regions And Uses Thereof App 20180186863 - FREY; GERHARD ;   et al. | 2018-07-05 |
Mirac proteins Grant 9,994,841 - Short , et al. June 12, 2 | 2018-06-12 |
Mirac proteins Grant 9,982,252 - Short , et al. May 29, 2 | 2018-05-29 |
Multi-specific monoclonal antibodies Grant 9,969,813 - Frey , et al. May 15, 2 | 2018-05-15 |
Anti-cd22 Antibodies App 20180086843 - Short; Jay ;   et al. | 2018-03-29 |
Anti-CD22 antibodies Grant 9,856,323 - Short , et al. January 2, 2 | 2018-01-02 |
Mirac Proteins App 20170369867 - Short; Jay M. ;   et al. | 2017-12-28 |
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells App 20170260261 - Short; Jay M. | 2017-09-14 |
Express Humanization Of Antibodies App 20170247473 - Short; Jay M. | 2017-08-31 |
Discovering And Producing Conditionally Active Biologic Proteins In The Same Eukaryotic Cell Production Hosts App 20170247685 - Short; Jay M. | 2017-08-31 |
Diagnostics Using Conditionally Active Antibodies App 20170199198 - Short; Jay M. | 2017-07-13 |
Conditionally Active Biological Proteins App 20170191055 - Short; Jay M. ;   et al. | 2017-07-06 |
Mirac proteins Grant 9,637,735 - Short , et al. May 2, 2 | 2017-05-02 |
Mirac proteins Grant 9,637,734 - Short , et al. May 2, 2 | 2017-05-02 |
Mirac Proteins App 20170044522 - Short; Jay M. ;   et al. | 2017-02-16 |
Mirac proteins Grant 9,464,284 - Short , et al. October 11, 2 | 2016-10-11 |
Conditionally Active Chimeric Antigen Receptors For Modified T-cells App 20160207989 - Short; Jay M. | 2016-07-21 |
Multi-specific Monoclonal Antibodies App 20150252119 - Frey; Gerhard ;   et al. | 2015-09-10 |
Anti-cd22 Antibodies App 20150086562 - Short; Jay ;   et al. | 2015-03-26 |
Modified Antibody Regions And Uses Thereof App 20150065690 - Frey; Gerhard ;   et al. | 2015-03-05 |
Simultaneous, Integrated Selection And Evolution Of Antibody/protein Performance And Expression In Production Hosts App 20150024944 - Short; Jay Milton | 2015-01-22 |
Mirac Proteins App 20140378660 - Short; Jay M. ;   et al. | 2014-12-25 |
Mirac Proteins App 20140356344 - Short; Jay M. ;   et al. | 2014-12-04 |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Grant 8,859,467 - Short October 14, 2 | 2014-10-14 |
Mirac Proteins App 20140187748 - Short; Jay M. ;   et al. | 2014-07-03 |
Mirac proteins Grant 8,709,755 - Short , et al. April 29, 2 | 2014-04-29 |
Express Humanization Of Antibodies App 20130303399 - Short; Jay M. | 2013-11-14 |
Comprehensive Monoclonal Antibody Generation App 20130281303 - Short; Jay M. | 2013-10-24 |
Novel Methods Of Protein Evolution App 20130116125 - Short; Jay M. | 2013-05-09 |
Mirac Proteins App 20120258865 - Short; Jay M. ;   et al. | 2012-10-11 |
Simultaneous, Integrated Selection And Evolution Of Antibody/protein Performance And Expression In Production Hosts App 20120245036 - Short; Jay Milton | 2012-09-27 |
Mirac Proteins App 20100260739 - Short; Jay M. ;   et al. | 2010-10-14 |
Humanized Anti-il-6 Antibodies App 20100138945 - Frey; Gerhard ;   et al. | 2010-06-03 |
NCAGE Code | 66RX2 | BIOATLA, LLC |
CAGE Code | 66RX2 | BIOATLA, LLC |
SEC | 0001614452 | BioAtla,LLC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.